This study deals with intoxications resulting from the use of atropine-like drugs: benztropine methanesulfonate*, trihexyphenidyl**, and procyclidine***. These medications are widely used to combat extrapyramidal side effects due to phenothiazine therapy.
In cases treated with phenothiazines, Biissow observed that an injection of benztropine methanesulfonate leads to decrease of drowsiness and increased alertness which may result in excitement and confusion (1). Severe reactions (dry mouth, confusion, hallucinations, urinary retention and glaucoma) with thera peutic doses and accidental intoxication from overdoses have been recorded (5, 10, 18) . It has been seen more often in elderly and atropine sensitive patients (15) . This atropine-like drug acts as an antagonist to acetylcholine on some thalamic structures which exert inhibitory influences on gamma fibre activity (5).
Clinical Data
In our experience, the prodromic signs were observed with recommended doses (4mg to 8mg) of the antiparkinsonian drug. Autonomic signs ushered in the onset of the delirium. The most common were dry mouth, blurring of vision, mydriasis, nocturnal disorientation, anorexia, severe constipation, irritability and tremor. Sometimes, we saw an exa cerbation of dyskinesias, facial myoclo nus and drug-induced parkinsonism. The emergence of the toxic-confusional stage was initiated by cloudiness of the sensorium with a dazed, perplexed and fear ful countenance, staggering gait, insom nia, disorientation in time and space, and visual hallucinations which cause the Canad. Psyohiat. Ass. J. Vol. 12 (1967) patient to grasp at the air and to pick imaginary objects from the skin. There was also evidence of dehydration (red tongue and cracked lips), dilated pupils, rapid pulse, difficulty or inability in voiding and severe constipation Hyperpathia, dysaesthesia and tactile hallu cinations pointed to a thalamic syn drome. 
General Discussion
Toxic-confusional states during ad ministration of psychotropic drugs have been observed. They occurred in three out of 137 cases treated with imipramine (250mg to 300mg per day) (3). Three other cases were reported to have suf fered from visual hallucinoses (colourful figures, little men or landscapes) without disturbance of consciousness (4). Lehmann (16) found five cases of .toxic visual hallucinations in 84 patients treated with imipramine. The atropine-like action of this antidepressant compound may ex plain its potential toxic hazards (19) .
Fewer reports have been published on the untoward toxic psychoses induced by phenothiazine therapy. It has been no ticed that arteriosclerotics, chronic alco holics and other kinds of brain-damaged patients sometimes exhibited increased confusion and/or delirium which sub sided following the withdrawal of pheno thiazines (2). Kinross-Wright (quoted by Hollister [9] ) reported two fatal cases of toxic confusional states from chlorpromazine. Clinically, these patients did not show extrapyramidal signs while the post mortem revealed neuronal de generation in the hypothalamus, globus pallidus, subthalamic body and amygda loid nucleus. One patient described by Lang (13) developed drowsiness, panic like mood, visual hallucinations, dysar thria and dysphagia during treatment with chlorpromazine. These symptoms were reproduced during treatment with trifluoperazine.
Helmchen et al (7) reported seventeen cases of toxic psychoses in 291 females treated with psychotropic medications. Eight of them were placed on phenglutarimide (an antiparkinsonian drug) one to three days prior to the onset of the re action. The same authors (7) as well as Grahmann and Peters (6), emphasized the role of the deliriogenic potency of the drug (such as perazin, imipramine and phenglutarimide), of the triggering in fluence of rapid dosage changes (Dekompensationseffekt bei raschem Belastungswechsel) and of the drug mode of action according to the patient's age.
In our group of patients, we observed that certain combinations, of drugs in relatively high doses were particularly toxic. In one case (patient No. 8) upon disappearance of toxic psychotic symp toms, the patient was given a similar amount of benztropine alone (the drug we suspected responsible for the toxicity) for one week. This time she failed to develop a delirious state. The patient had trimipramine alone before adding benz tropine.
A second factor to be considered is that withdrawal (barbiturates, morphine or alcohol withdrawal) or rapid increase of medications may trigger a para-re sponse (rebound effect).
It has been observed that a certain number of patients are more susceptible to specific drugs while others are ex tremely resistant to them. This individual and racial difference in drug response, particularly in regard to atropine, is well established (11) .
The therapeutic significance of this short-lasting exogenous reaction type was stressed by some authors (6, 7, 8). In our experience most patients remained im proved without medications for several weeks. However upon return of func tional psychotic symptoms they had to be placed once more on drugs.
Consequently, more caution should be exercised in the use of antiparkinsonian and anticholinergic drugs because of the risk of inducing a toxic exogenous deli rium.
Summary
Nine cases of transient toxic-delirious reactions during combined antipsychoticantiparkinsonism treatment have been described. A few days prior to the onset of the reaction, all patients had been placed on an antiparkinsonian drug.
Three clinical phases were observed: an autonomic stage (sympathicotonic signs: mydriasis, dry mouth, anorexia, excitement, disorientation, insomnia, severe constipation); a strio-thalamic phase (dyskinesias, visual and tactile hal lucinations) and a post-delirious state (increased sleep and integration).
The pathogenic factors which play a role in this atropine-like toxic condition, such as age, individual susceptibility, drug response per se and the influence of rapid dose changes were briefly discussed. 
